| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 8e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.12 | 9e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0009 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |